
iTrials helps clinical researchers run trials faster and get patients access to medications sooner. It does this by combining cutting-edge technology with healthcare knowledge to shorten trial durations and accelerate study timelines. The company operates as a clinical trial technology platform that supports sponsors and research teams through analytics-driven workflow improvements. iTrials focuses on applying technical tools and domain expertise to optimize study processes and timelines. Its offering targets the clinical research market where faster trials reduce time-to-treatment.

iTrials helps clinical researchers run trials faster and get patients access to medications sooner. It does this by combining cutting-edge technology with healthcare knowledge to shorten trial durations and accelerate study timelines. The company operates as a clinical trial technology platform that supports sponsors and research teams through analytics-driven workflow improvements. iTrials focuses on applying technical tools and domain expertise to optimize study processes and timelines. Its offering targets the clinical research market where faster trials reduce time-to-treatment.
Founded: 2023
Headquarters: Palo Alto, California
Product: Elara — AI-driven patient matching and protocol feasibility
Focus: Accelerating clinical trial enrollment and shortening study timelines
Recent funding: $25,000 pre-seed (Mar 2024)
Clinical trial enrollment and protocol feasibility
2023
Data and Analytics
$25,000
Also reported in some sources as investment from the University of Chicago Innovation Fund for $25k.